Bckdk介导的分支链氨基酸新陈代谢重编程有助于癌症期间肌肉缩 Cachexia
Li Chen1, Hong Zhang1, Mengyi Chi1
1Department of Pharmacy, Shanghai Sixth People's Hospital Affiliated Shanghai Jiao Tong University School of Medicine, Shanghai, 200233, China.
Molecular nutrition & food research
|December 27, 2023
概括
分支链氨基酸 (BCAA) 代谢功能障碍加速癌症缓解症. 补充BCAA通过促进蛋白质合成和抑制受影响肌肉的降解来改善生存率.
科学领域:
- 生物化学 生物化学
- 分子生物学分子生物学
- 生理学 生理学 生理学
背景情况:
- 分链氨基酸 (BCAA) 是能量和蛋白质代谢至关重要的必需营养素.
- BCAA代谢功能障碍与各种生理条件有关,包括肌肉衰竭.
研究的目的:
- 为了研究BCAA代谢功能障碍在癌症缓解症中的作用.
- 探索BCAA补充剂在缓解肌肉衰竭方面的治疗潜力.
主要方法:
- 产生肌肉特异性的Bckdk条件淘汰 (cKO) 鼠标.
- 使用易斯肺癌 (LLC) 瘤移植建立癌症缓解症模型.
- 分析骨肌肉中的蛋白质合成和降解途径.
主要成果:
- 肌肉特异性的Bckdk-cKO小鼠表现出加速的癌症缓解症,蛋白质无化增加和合成受损.
- 在携带LCL瘤的cKO小鼠中补充BCAA改善了生存率和缓解了缓解缓解.
- 补充BCAA促进了蛋白质合成,并抑制了骨肌肉中的蛋白质降解.
结论:
- 功能障碍的BCAA新陈代谢加剧了癌症缓解症中的肌肉损耗.
- 通过补充剂重新编程BCAA代谢提供了一种治疗策略,以保持肌肉质量.
相关概念视频
Overview of Protein Metabolism
1.2K
Proteins are broken down into amino acids during digestion. Unlike fats and carbohydrates, which are stored for later use, proteins are not. Instead, amino acids are either used to produce ATP through oxidation or contribute to the creation of new proteins for the growth and repair of the body. Any surplus amino acids from the diet are converted into glucose or triglycerides rather than excreted.
Amino acids play various roles in the body once they are absorbed into cells. They are restructured...
Amino acids play various roles in the body once they are absorbed into cells. They are restructured...
1.2K
Cross-bridge Cycle
117.5K
As muscle contracts, the overlap between the thin and thick filaments increases, decreasing the length of the sarcomere—the contractile unit of the muscle—using energy in the form of ATP. At the molecular level, this is a cyclic, multistep process that involves binding and hydrolysis of ATP, and movement of actin by myosin.
117.5K
Adaptive Mechanisms in Cancer Cells
5.8K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.8K
mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
Electron Transport Chain: Complex I and II
13.5K
The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
ROS generation is regulated and maintained at moderate levels necessary...
13.5K
The Intrinsic Apoptotic Pathway
6.6K
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
6.6K


